A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions

Introduction To integrate and execute a proper preventive plan reduce the risk of non-communicable diseases (NCDs), policy makers need to have access both reliable data unique definition metabolic syndrome (MetS). This study was conducted on collected by cross-sectional studies WHO’s STEPwise approach surveillance NCD factors (STEPs) estimate national sub-national prevalence rates MetS in Iran 2016. Materials methods The estimated among 18,414 individuals aged ≥25 years living urban rural areas using various criteria; National Cholesterol Education Program Adult Treatment Panel III 2004 (ATP III), International Diabetes Federation (IDF), American Heart Association/National Heart, Lung, Blood Institute (AHA/NHLBI), Joint Interim Statement (JIS). Regional IDF (RIDF) JIS (RJIS) were defined ethnicity-specific values waist circumference for country. Results rate based ATP III, IDF, AHA/NHLBI, JIS, RIDF RJIS criteria 38.3% (95% CI 37.4–39.1), 43.5% (42.7–44.4), 40.9% (40.1–41.8), 47.6% (46.8–48.5), 32.0% (31.2–32.9), 40.8% (40.0–41.7), respectively. higher females, residents, those 65–69 years. expected affect about 18.7, 21.3, 20.0, 23.3, 15.7, 20.0 million Iranians, respectively, RJIS. two most common components noted this population reduced high-density lipoprotein cholesterol (HDL-C) levels central obesity. Conclusion High Iranian adults is alarming, especially elderly. more appropriate determine number Iranians at NCDs. Proper management prevention required adopt multiple plans including lifestyle modifications, medical interventions, public education NCDs factors.